STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis

Clinical trial NCT07332325 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07332325
Sponsor: University of Virginia
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sepsis Tuberculosis

Start date: 2026-10-01
Primary completion: 2029-03-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.